National Cancer Institute (NCI) PDQ Adult Treatment Editorial Board, 2025-05-14: For stage I disease the NCI PDQ lists surveillance, surgery, radiation, brachytherapy and investigational local therapies – no chemotherapy. The same structure holds for stages II and III; chemotherapy first appears in the stage IV list.
Treatment options for patients with stage I prostate cancer include: Watchful waiting or active surveillance/active monitoring. Radical prostatectomy. External-beam radiation therapy (EBRT). Interstitial implantation of radioisotopes. High-intensity focused ultrasound therapy (under clinical evaluation). Photodynamic therapy (under clinical evaluation).
HTML, unpaginated
National Cancer Institute (NCI) PDQ Adult Treatment Editorial Board, 2025-05-14: For stage I disease the NCI PDQ lists surveillance, surgery, radiation, brachytherapy and investigational local therapies – no chemotherapy. The same structure holds for stages II and III; chemotherapy first appears in the stage IV list. Same document as CHH-04 (same PDQ page); fold into CHH-04 at combine. Stage I options list surveillance, prostatectomy, EBRT, brachytherapy and investigational local therapies – no chemotherapy; the same holds for stages II and III. Also filed as CHH-04 (claims C1, F1). Study type: review.
